4.6 Article

Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey

Journal

LANCET GLOBAL HEALTH
Volume 9, Issue 6, Pages E773-E781

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S2214-109X(21)00053-X

Keywords

US Centers for Disease Control and Prevention

Funding

  1. US President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention (CDC)
  2. CDC

Ask authors/readers for more resources

The study revealed a significantly higher estimated number of SARS-CoV-2 infections compared to reported cases in six districts in Zambia. The high rtPCR-positive prevalence indicated community transmission, while the low ELISA-positive prevalence was likely influenced by early mitigation measures. It is important for Zambia to monitor the prevalence of SARS-CoV-2 and implement measures to reduce transmission.
Interpretation The estimated number of SARS-CoV-2 infections was much higher than the number of reported cases in six districts in Zambia. The high rtPCR-positive SARS-CoV-2 prevalence was consistent with observed community transmission during the study period. The low ELISA-positive SARS-CoV-2 prevalence might be associated with mitigation measures instituted after initial cases were reported in March, 2020. Zambia should monitor patterns of SARS-CoV-2 prevalence and promote measures that can reduce transmission. Findings Overall, 4258 people from 1866 households participated in the study. The median age of participants was 18 center dot 2 years (IQR 7 center dot 7-31 center dot 4) and 50 center dot 6% of participants were female. SARS-CoV-2 prevalence for the combined measure was 10 center dot 6% (95% CI 7 center dot 3-13 center dot 9). The rtPCR-positive prevalence was 7 center dot 6% (4 center dot 7-10 center dot 6) and ELISA-positive prevalence was 2 center dot 1% (1 center dot 1-3 center dot 1). An estimated 454 708 SARS-CoV-2 infections (95% CI 312 705-596 713) occurred in the six districts between March and July, 2020, compared with 4917 laboratory-confirmed cases reported in official Methods Between July 4 and July 27, 2020, we did a cross-sectional cluster-sample survey of households in six districts of Zambia. Within each district, 16 standardised enumeration areas were randomly selected as primary sampling units using probability proportional to size. 20 households from each standardised enumeration area were selected using simple random sampling. All members of selected households were eligible to participate. Consenting participants completed a questionnaire and were tested for SARS-CoV-2 infection using real-time PCR (rtPCR) and anti-SARS-CoV-2 antibodies using ELISA. Prevalence estimates, adjusted for the survey design, were calculated for each diagnostic test separately, and combined. We applied the prevalence estimates to census population projections for each district to derive the estimated number of SARS-CoV-2 infections. Summary Background Between March and December, 2020, more than 20 000 laboratory-confirmed cases of SARS-CoV-2 infection were reported in Zambia. However, the number of SARS-CoV-2 infections is likely to be higher than the confirmed case counts because many infected people have mild or no symptoms, and limitations exist with regard to testing capacity and surveillance systems in Zambia. We aimed to estimate SARS-CoV-2 prevalence in six districts of Zambia in July, 2020, using a population-based household survey. Methods Between July 4 and July 27, 2020, we did a cross-sectional cluster-sample survey of households in six districts of Zambia. Within each district, 16 standardised enumeration areas were randomly selected as primary sampling units using probability proportional to size. 20 households from each standardised enumeration area were selected using simple random sampling. All members of selected households were eligible to participate. Consenting participants completed a questionnaire and were tested for SARS-CoV-2 infection using real-time PCR (rtPCR) and anti-SARS-CoV-2 antibodies using ELISA. Prevalence estimates, adjusted for the survey design, were calculated for each diagnostic test separately, and combined. We applied the prevalence estimates to census population projections for each district to derive the estimated number of SARS-CoV-2 infections. Findings Overall, 4258 people from 1866 households participated in the study. The median age of participants was 18 center dot 2 years (IQR 7 center dot 7-31 center dot 4) and 50 center dot 6% of participants were female. SARS-CoV-2 prevalence for the combined measure was 10 center dot 6% (95% CI 7 center dot 3-13 center dot 9). The rtPCR-positive prevalence was 7 center dot 6% (4 center dot 7-10 center dot 6) and ELISA-positive prevalence was 2 center dot 1% (1 center dot 1-3 center dot 1). An estimated 454 708 SARS-CoV-2 infections (95% CI 312 705-596 713) occurred in the six districts between March and July, 2020, compared with 4917 laboratory-confirmed cases reported in official statistics from the Zambia National Public Health Institute. Interpretation The estimated number of SARS-CoV-2 infections was much higher than the number of reported cases in six districts in Zambia. The high rtPCR-positive SARS-CoV-2 prevalence was consistent with observed community transmission during the study period. The low ELISA-positive SARS-CoV-2 prevalence might be associated with mitigation measures instituted after initial cases were reported in March, 2020. Zambia should monitor patterns of SARS-CoV-2 prevalence and promote measures that can reduce transmission.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available